Yüklüyor......
SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells
Cisplatin and other platinum-based compounds are frequently used to treat breast cancer, but their utility is severely compromised by drug resistance. Many genes dictating drug responsiveness are subject to pre-mRNA alternative splicing which is regulated by key kinases such as the serine-arginine p...
Kaydedildi:
| Yayımlandı: | Commun Biol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group UK
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7253463/ https://ncbi.nlm.nih.gov/pubmed/32461560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-020-0983-4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|